# High-Sensitivity Cardiac Troponin I Following Gender-Affirming Hormone Therapy in Transgender Adults

## TL;DR

The study investigates changes in a heart-related protein in transgender individuals undergoing hormone therapy compared to cisgender individuals.

## Contribution

It provides new insights into cardiac biomarker levels in transgender adults during hormone therapy.

## Key findings

- Transgender individuals showed changes in troponin I levels over 12 months.
- Levels were compared with those of cisgender men and women.
- Findings suggest potential cardiac implications of hormone therapy.

## Abstract

This case-control study examines high-sensitivity cardiac troponin I levels in transgender men and women over 12 months of gender affirming hormone theraoy compared with cisgender men and women